J Korean Med Assoc.  2012 Aug;55(8):779-790. 10.5124/jkma.2012.55.8.779.

Management of adverse reaction to iodinated radiocontrast media

• Shin MJ
• Cho YJ

• KMID: 1435184
• DOI: http://doi.org/10.5124/jkma.2012.55.8.779

Abstract

Application of iodinated radiographic contrast media (RCM) has increased recently because of the number of computed tomography examinations using RCM is increasing rapidly. The awareness regarding potential adverse reactions due to contrast media and the necessary precautions to be taken is of utmost importance both for radiologists and referring physicians since the adverse reactions including hypersensitivity reactions to RCM are still unpredictable and reported in significantly increasing number among exposed patients year by year. In 2011, Korean guideline for the safe use of RCM was published by the Korean Society of Radiology and Korean Academy of Asthma, Allergy and Clinical Immunology. On behalf of these organizations a committee named Korean Network of Allergists & Radiologists for Research of Radio-contrast Media-associated Adverse Reactions (KOAR3A) was formed and collaborated to develop guidelines. Its major purpose is to provide a clinically practical and evidence-based manual full of useful information regarding patient screening, premedication, recognition of adverse reactions, and emergency treatment of such reactions in daily practice as well as other problems, especially kidney toxicity and endocrine problems in consultation with the corresponding medical specialists.

Keyword

Radiocontrast media; Injection, intravenous; Computed tomography; Adverse drug reaction; Hypersensitivity

MeSH Terms

Asthma
Contrast Media
Drug Toxicity
Emergency Treatment
Humans
Hypersensitivity
Injections, Intravenous
Kidney
Mass Screening
Premedication
Specialization
Contrast Media

Figure

• 

  Figure 1 Intramuscular injection site: anterolateral aspect of mid-thigh.

Reference

1. Christiansen C. X-ray contrast media: an overview. Toxicology. 2005. 209:185–187.

2. Brockow K, Ring J. Classification and pathophysiology of radiocontrast media hypersensitivity. Chem Immunol Allergy. 2010. 95:157–169.

3. Wolf GL, Arenson RL, Cross AP. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of adverse effects. AJR Am J Roentgenol. 1989. 152:939–944.

4. Caro JJ, Trindade E, McGregor M. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis. AJR Am J Roentgenol. 1991. 156:825–832.

5. Vogl TJ, Honold E, Wolf M, Mohajeri H, Hammerstingl R. Safety of iobitridol in the general population and at-risk patients. Eur Radiol. 2006. 16:1288–1297.

6. Gomi T, Nagamoto M, Hasegawa M, Katoh A, Sugiyama M, Murata N, Kunihiro T, Kohda E. Are there any differences in acute adverse reactions among five low-osmolar non-ionic iodinated contrast media? Eur Radiol. 2010. 20:1631–1635.

7. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990. 175:621–628.

8. Kim SS, Park CH, Park MJ, Choi SH, Kim YS, Park HW, Chang YS, Shin CS, Oh BH, Min KU, Kim YY, Cho SH. Adverse reactions to radio-contrast media in computed tomography (CT) in general population: incidence and clinical features. Korean J Asthma Allergy Clin Immunol. 2007. 27:157–161.

9. American College of Radiology. Manual on contrast media v7. 2010. cited 2012 Jul 18. Reston (VA): American College of Radiology;Available from: http://www.acr.org/Quality-Safety/Resources/Contrast-Manual.

10. European Society of Urogenital Radiology. SUR guidelines on contrast media: version 7.0. 2009. cited 2012 Jul 18. Vienna: European Society of Urogenital Radiology;Available from: http://www.esur.org/Contrast-media.51.0.html.

11. Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY. World Allergy Organization. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol. 2011. 127:587593593.e1–593.e22.

12. Brockow K, Romano A, Aberer W, Bircher AJ, Barbaud A, Bonadonna P, Faria E, Kanny G, Lerch M, Pichler WJ, Ring J, Rodrigues Cernadas J, Tomaz E, Demoly P, Christiansen C. European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy. 2009. 64:234–241.

13. Brockow K, Ring J. Anaphylaxis to radiographic contrast media. Curr Opin Allergy Clin Immunol. 2011. 11:326–331.

14. Caimmi S, Benyahia B, Suau D, Bousquet-Rouanet L, Caimmi D, Bousquet PJ, Demoly P. Clinical value of negative skin tests to iodinated contrast media. Clin Exp Allergy. 2010. 40:805–810.

15. Goksel O, Aydın O, Atasoy C, Akyar S, Demirel YS, Misirligil Z, Bavbek S. Hypersensitivity reactions to contrast media: pre-valence, risk factors and the role of skin tests in diagnosis--a cross-sectional survey. Int Arch Allergy Immunol. 2011. 155:297–305.

16. Kim SH, Lee SH, Lee SM, Kang HR, Park HW, Kim SS, Cho SH, Min KU, Kim YY, Chang YS. Outcomes of premedication for non-ionic radio-contrast media hypersensitivity reactions in Korea. Eur J Radiol. 2011. 80:363–367.

17. Mayorga C, Sanz ML, Gamboa PM, Garcia BE, Caballero MT, Garcia JM, Labrador M, Lahoz C, Longo Areso N, Lopez Hoyos M, Martinez Quesada J, Monteseirin FJ. Immunology Committee of the Spanish Society of Allergology and Clinical Immunology of the SEAIC. In vitro diagnosis of immediate allergic reactions to drugs: an update. J Investig Allergol Clin Immunol. 2010. 20:103–109.

18. Korean Society of Radiology. Korean Academy of Asthma, Allergy and Clinical Immunology. Clinical practice guideline of adverse drug reactions to the intravenous iodinated radiocontrast media in Korea. 2011. 1st ed. Seoul: Korean Society of Radiology; Korean Academy of Asthma, Allergy and Clinical Immunology.